OQS
ABCL icon

Occudo Quantitative Strategies’s AbCellera Biologics ABCL Stock Holding History

Occudo Quantitative Strategies’s Portfolio ABCL Stock Details ABCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-13,630
Closed -$61.7K – 719
2024
Q1 		$61.7K Buy
+13,630
New +$69.6K 0.01% 681
2022
Q4 		– Sell
-162,885
Closed -$1.61M – 919
2022
Q3 		$1.61M Buy
162,885
+68,562
+73% +$752K 0.13% 242
2022
Q2 		$1M Sell
94,323
-22,445
-19% -$190K 0.08% 383
2022
Q1 		$1.14M Buy
116,768
+89,901
+335% +$851K 0.1% 342
2021
Q4 		$384K Buy
+26,867
New +$408K 0.03% 696

Other funds holding ABCL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $116B AUM 61.47% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FFVM
Founders Fund VII Management San Francisco, California $2.03M AUM 72.34% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Occudo Quantitative Strategies's ABCL Position: Q2 2024 in Review

Occudo Quantitative Strategies sold out of AbCellera Biologics (ABCL) in Q2 2024, closing a stake of 13,630 shares — an estimated $61.7K sold.

Occudo Quantitative Strategies first reported a position in ABCL in Q4 2021 and held it in 5 quarters. The position peaked at $1.61M in Q3 2022. 147 funds tracked by Wall St. Rank hold ABCL as of Q2 2024.

  • Occudo Quantitative Strategies reported no remaining AbCellera Biologics position as of Q2 2024 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 13,630 AbCellera Biologics shares in Q2 2024, an estimated $61.7K.
  • Occudo Quantitative Strategies first reported a position in AbCellera Biologics in Q4 2021 and held it in 5 quarters.
  • Occudo Quantitative Strategies's AbCellera Biologics position peaked at $1.61M in Q3 2022.
  • 147 funds tracked by Wall St. Rank held AbCellera Biologics as of Q2 2024.

Based on Occudo Quantitative Strategies's 13F filing for Q2 2024, filed 14 Aug 2024.